Disclosed are: an anti-tumor agent; and a method for screening for the anti-tumor agent. The anti-tumor agent comprises an inhibitory substance capable of inhibiting the function of CCL19 or CCL21. The anti-tumor agent can be identified by determining whether or not a candidate compound for the anti-tumor agent inhibits the function of CCL19 or CCL21.